SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
BOSTON, United States and ROLLE, Switzerland, April 23, 2024 — SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S....
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa Boston, MA and Rolle, Switzerland, April 23, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in...
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment Boston, MA and Rolle, Switzerland, April 17, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a...
Decoding complexity: Tackling real-world challenges in variant analysis
Welcome to the inaugural episode of our new webinar series - Decoding complexity: Tackling real-world challenges in variant analysis. Prepare to embark on an enlightening journey as we tap into the wealth of knowledge possessed by our esteemed bioinformatics...
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
The Chile-based Laboratory is using SOPHiA GENETICS’ platform to advance its research capabilities with blood disorders BOSTON, US and Rolle, Switzerland, April 2, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in...
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
The companies will join forces to advance the use of precision medicine on a global scale Boston, MA and Rolle, Switzerland, April 4, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven...
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
University of Saskatchewan’s (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™ Platform to advance research on ovarian cancer care Boston, MA and Rolle, Switzerland, March 20, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software...
Tri-Con 2024
SOPHiA GENETICS™ is excited to be a part of the 31st International Precision Med Tri-Con Conference, held in person in San Diego, California from March 26th – 28th. Stop by booth #124 for a chance to meet our experts, get a sneak peak into the capabilities of...
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research Boston, MA and Rolle, Switzerland, March 15, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven...
ESGO Poster spotlight
Watch our poster spotlight interview, hosting Dr.Gardenia Vargas from Hospital del Mar in Barcelona, Spain discussing the poster presentation at ESGO 2024: “Multicenter Study To Validate And Implement SOPHiA DDM™ HRD Solution For Enhanced Molecular Diagnosis Of Ovarian Cancer.“
Addressing pharmacogenetics in routine NGS workflows
At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. In this Webinar our partners share how the analytical technology and...
Article Spotlight: Machine learning-powered prediction of kidney cancer recurrence
Discover how we collaborated with the UroCCR network to develop a machine learning model that outperformed the predictive performance of most usual kidney cancer risk scores.
SOPHiA GENETICS Announces New Customer in Costa Rica
Universidad de Costa Rica is live on SOPHiA GENETICS’ technology Boston, MA and Rolle, Switzerland, March 6, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that...
USCAP 2024
SOPHiA GENETICS™ is excited to be a part of the 113th United States and Canadian Academy of Pathology annual meeting, held in person in Baltimore, Maryland from March 23rd – 28th . Stop by booth # 1153 for a chance to meet our experts, get a sneak peak into...
